Citation Impact
Citing Papers
Conflict of Interest in Medical Research, Education, and Practice
2009 Standout
Interventions to improve antibiotic prescribing practices for hospital inpatients
2017 Standout
Predictors of Postoperative Pain and Analgesic Consumption
2009 Standout
Trace mycotoxin analysis in complex biological and food matrices by liquid chromatography–atmospheric pressure ionisation mass spectrometry
2006
Comparison of hydroxychloroquine with zidovudine in asymptomatic patients infected with human immunodeficiency virus type 1
1997
A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy
1996
Hydroxychloroquine treatment of patients with human immunodeficiency virus type 1
1995
Effects of the Antifungal Agents on Oxidative Drug Metabolism
2000
Characteristics of SARS-CoV-2 and COVID-19
2020 Standout
Mechanism and medical implications of mammalian autophagy
2018 Standout
Nrf2-Keap1 signaling in oxidative and reductive stress
2018 Standout
Population Pharmacokinetics of Hydroxychloroquine in Patients With Rheumatoid Arthritis
2003
Hydroxychloroquine cardiotoxicity in systemic lupus erythematosus: a report of 2 cases and review of the literature
2004
Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology
2020 Standout
Current role of LC-MS in therapeutic drug monitoring
2007
Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review
2008 Standout
Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions
2014 Standout
Concerns about pharmacokinetic (PK) and pharmacokinetic-pharmacodynamic (PK-PD) studies in the new therapeutic area of COVID-19 infection
2020
Mechanism of action of hydroxychloroquine as an antirheumatic drug
1993
Spinal cord stimulation versus conventional medical management for neuropathic pain: A multicentre randomised controlled trial in patients with failed back surgery syndrome
2007 Standout
Applying Linear and Non-Linear Methods for Parallel Prediction of Volume of Distribution and Fraction of Unbound Drug
2013
Can clinical pharmacy services have a positive impact on drug-related problems and health outcomes in community-based older adults?
2004
Autophagy: Renovation of Cells and Tissues
2011 Standout
Biological Functions of Autophagy Genes: A Disease Perspective
2019 Standout
Pancreatic Adenocarcinoma
2014 Standout
Combined autophagy and proteasome inhibition
2014
Pancreatic cancers require autophagy for tumor growth
2011
Autophagy and Tumor Metabolism
2017
Insights from nanomedicine into chloroquine efficacy against COVID-19
2020 Standout
Interventions to improve antibiotic prescribing practices for hospital inpatients
2013 Standout
The Evolution of Population Pharmacokinetic Models to Describe the Enterohepatic Recycling of Mycophenolic Acid in Solid Organ Transplantation and Autoimmune Disease
2010
Empirical management of community-acquired pneumonia: impact of concurrent A/H1N1 influenza pandemic on guideline implementation
2011
Effectiveness of Pharmacist Care for Patients With Reactive Airways Disease
2002
Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus
2006
Clinical Pharmacokinetics of Fluconazole in Superficial and Systemic Mycoses
1997
Acute kidney injury
2021 Standout
Dynamics and functions of lipid droplets
2018 Standout
Following the Script: How Drug Reps Make Friends and Influence Doctors
2007 Standout
Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: A study of one hundred thirty‐three cases compared with a control group
2003
Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases
2015
Autophagy in Human Health and Disease
2013 Standout
Therapeutic Drug Monitoring of Mycophenolate Mofetil in Transplantation
2006
Autophagy modulation as a potential therapeutic target for diverse diseases
2012 Standout
The trinity of COVID-19: immunity, inflammation and intervention
2020 Standout
Promotion of Prescription Drugs to Consumers and Providers, 2001–2010
2013
Appropriate prescribing in elderly people: how well can it be measured and optimised?
2007 Standout
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages
2020 Standout
Effects of chloroquine on viral infections: an old drug against today's diseases
2003 Standout
Implications of augmented renal clearance in critically ill patients
2011
Targeting autophagy in cancer
2017 Standout
Hydroxychloroquine in lupus pregnancy
2006
Critical issues on opioids in chronic non-cancer pain:
2006
Inhibition of HIV-1 replication by hydroxychloroquine: mechanism of action and comparison with zidovudine
1996
Dose-loading with hydroxychloroquine improves the rate of response in early, active rheumatoid arthritis: A randomized, double-blind six-week trial with eighteen-week extension
1999
Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision)
2016 Standout
Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors
2002 StandoutNature
Expanding horizons for clinical applications of chloroquine, hydroxychloroquine, and related structural analogues
2019
Perceptions of the Influence of Prescription Medicine Samples on Prescribing by Family Physicians
2006
Revised Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy
2011 Standout
Bioluminescent sensor proteins for point-of-care therapeutic drug monitoring
2014 StandoutNobel
ROS signalling in the biology of cancer
2017 Standout
Antimalarials – are they effective and safe in rheumatic diseases?
2018
Conflict of Interest in Clinical Practice Guideline Development: A Systematic Review
2011 Standout
COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology
2020
Audit and feedback of antibiotic use
2013
Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results
2020 Standout
Chloroquine gestational use in systemic lupus erythematosus: assessing the risk of child ototoxicity by pure tone audiometry
2004
Audit and feedback: effects on professional practice and healthcare outcomes
2012 Standout
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19)
2020 Standout
pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures
2015 Standout
Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19
2020 Standout
Association of Perfluoroalkyl Substances, Bone Mineral Density, and Osteoporosis in the U.S. Population in NHANES 2009–2010
2015
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (April 2020)
2020 Standout
Dyslipidemia: Reduction in Estimated Risk for Coronary Artery Disease After Use of Ezetimibe with a Statin
2007
Trends in Prescription Drug Use Among Adults in the United States From 1999-2012
2015 Standout
Interventions for enhancing medication adherence
2008 Standout
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Targeting Autophagy Addiction in Cancer
2011
Per- and Polyfluoroalkyl Substance Toxicity and Human Health Review: Current State of Knowledge and Strategies for Informing Future Research
2020 Standout
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Interventions for enhancing medication adherence
2014 Standout
Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections
2010 Standout
Opioid Prescriptions for Chronic Pain and Overdose
2010 Standout
The Metabolic Syndrome
2008 Standout
Impact of a pharmaceutical care model for non-institutionalised elderly: results of a randomised, controlled trial
2001
Clearance and beyond: the complementary roles of GFR measurement and injury biomarkers in acute kidney injury (AKI)
2011
Occurrence of Mycotoxins in Feed as Analyzed by a Multi-Mycotoxin LC-MS/MS Method
2009 Standout
Pharmacokinetics of Hydroxychloroquine and Its Clinical Implications in Chemoprophylaxis against Malaria Caused byPlasmodium vivax
2009
The Risk of Toxic Retinopathy in Patients on Long-term Hydroxychloroquine Therapy
2014 Standout
Perioperative Management of Acute Pain in the Opioid-dependent Patient
2004
In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
2020 Standout
Achieving Integration in Mixed Methods Designs—Principles and Practices
2013 Standout
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19
2020 Standout
Works of S. E. Tett being referenced
Concentration-effect relationship of hydroxychloroquine in rheumatoid arthritis--a cross sectional study.
1993
Apparent dose-dependence of chloroquine pharmacokinetics due to limited assay sensitivity and short sampling times
1987
Impact of Pharmacist Interventions on Medication Management by the Elderly: A Review of the Literature
1993
Quantification of free mycophenolic acid and its glucuronide metabolite in human plasma by liquid-chromatography using mass spectrometric and ultraviolet absorbance detection
2003
Validity of self-reported osteoporosis in mid-age and older women
2012
Population pharmacokinetic analysis of mycophenolic acid in renal transplant recipients following oral administration of mycophenolate mofetil
2003
A quality improvement initiative to improve adherence to national guidelines for empiric management of community-acquired pneumonia in emergency departments
2010
Prescription drug samples - does this marketing strategy counteract policies for quality use of medicines?
2003
Quantifying the use of the statin antilipemic drugs: Comparisons and contrasts between Nova Scotia, Canada, and Queensland, Australia
2005
BIOAVAILABILITY OF HYDROXYCHLOROQUINE TABLETS IN PATIENTS WITH RHEUMATOID ARTHRITIS
1994
Absorption and in vivo dissolution of hydroxycholoroquine in fed subjects assessed using deconvolution techniques
1993
Simultaneous administration of a cocktail of markers to measure renal drug elimination pathways: absence of a pharmacokinetic interaction between fluconazole and sinistrin, p‐aminohippuric acid and pindolol
2001
Impact of Mycophenolate Mofetil Loading on Drug Exposure in the Early Posttransplant Period
2005
Opioid analgesic prescribing and use – an audit of analgesic prescribing by general practitioners and The Multidisciplinary Pain Centre at Royal Brisbane Hospital
2001
Pharmacokinetics and Cellular Uptake of 4-Aminoquinoline Antimalarials
1988
Insights from pharmacokinetic and pharmacodynamic studies of hydroxychloroquine.
1993
Disposition of the enantiomers of hydroxychloroquine in patients with rheumatoid arthritis following multiple doses of the racemate.
1993
A cross‐sectional study of hydroxychloroquine concentrations and effects in people with systemic lupus erythematosus
2013
Bioavailability of hydroxychloroquine tablets in healthy volunteers.
1989
Pharmacokinetics and bioavailability of fluconazole in two groups of males with human immunodeficiency virus (HIV) infection compared with those in a group of males without HIV infection
1995
Concentration-effect relationship of hydroxychloroquine in patients with rheumatoid arthritis--a prospective, dose ranging study.
2000
High-performance liquid chromatographic assay for hydroxychloroquine and metabolites in blood and plasma, using a stationary phase of poly(styrene divinylbenzene) and a mobile phase at ph 11, with fluorimetric detection
1985
A dose‐ranging study of the pharmacokinetics of hydroxy‐chloroquine following intravenous administration to healthy volunteers.
1988